Thymoglobuline

Thymoglobuline is an anti-T lymphocyte immunoglobulin derived from rabbit serum, used to modulate immune responses. It is administered intravenously for immune system support. This product is manufactured by Sanofi B.V. and originates from the EU.

Thymoglobuline is primarily used to prevent organ transplant rejection by reducing the activity of T-cells in the immune system. It may also be used in the treatment of certain autoimmune conditions where immune system overactivity is a concern. Patients often ask, 'what is Thymoglobuline used for' in transplant medicine and immune modulation contexts.

Thymoglobuline works by targeting and depleting T-cells, which are key players in the immune response. This helps to reduce the risk of immune-mediated damage to transplanted organs or overactive immune responses in autoimmune conditions. Users may experience effects related to immune system modulation during treatment.

Thymoglobuline should be handled and administered by healthcare professionals due to its potent effects on the immune system. Patients must be monitored closely for signs of infection or allergic reactions during and after treatment. Proper storage and handling according to manufacturer guidelines are essential to maintain product integrity.

Thymoglobuline may interact with other immunosuppressants or medications that affect the immune system, potentially increasing the risk of infection or other complications. Live vaccines should be avoided during treatment, as the immune response may be insufficient. Patients should inform their healthcare provider about all medications they are taking.